20 August 2024 : Original article
One-Year Mortality After Lung Transplantation: Experience of a Single French Center Between 2012 and 2021
Thi Cam Tu Hoang1ABCDEF, Lien Han2CDE, Sandrine Hirschi1ADEF, Tristan Degot1ADEF, Justine Leroux1ADEF, Pierre-Emmanuel Falcoz
3ADEF, Anne Olland34ADEF, Nicola Santelmo3ADEF, Marion Villard3BF, Olivier Collange5ADEF, Gauthier Appere5ADEF, Romain Kessler14ADEF, Benjamin Renaud-Picard 14ACDEF*
DOI: 10.12659/AOT.944420
Ann Transplant 2024; 29:e944420
Table 1 Characteristics of lung transplant patients followed up at Strasbourg University Hospital between 2012 and 2021.
| Patient characteristics | n=425 | |
|---|---|---|
| Age at transplantation (years old) | Median [IQR] | 57 [48;62] |
| Male patients | n, % | 235 (55.3%) |
| BMI (kg/m) | Median [IQR] | 22 [19;26] |
| Waiting time from listing to transplantation (months) | Median [IQR] | 3 [1;7] |
| 105 (24.7%) | ||
| 1–6 months (n, %) | 201 (47.3%) | |
| 6–12 months (n, %) | 86 (20.2%) | |
| >12 months (n, %) | 33 (7.8%) | |
| Organ transplanted | Lung transplant (n, %) | 402 (94.6%) |
| Heart-lung transplant (n, %) | 17 (4.0%) | |
| Pancreatic islet-lung transplant (n, %) | 6 (1.4%) | |
| Indication for lung transplantation | ILD (n, %) | 84 (19.8%) |
| COPD or A1ATd (n, %) | 217 (51.1%) | |
| CF (n, %) | 54 (12.7%) | |
| PAH (n, %) | 23 (5.4%) | |
| Re-transplantation (n, %) | 13 (3.1%) | |
| Others (n, %) | 34 (8.0%) | |
| Transplant type | Unilateral (n, %) | 15 (3.5%) |
| Bilateral (n, %) | 410 (96.5%) | |
| Super-urgent transplantation | n, % | 69 (16.2%) |
| IQR – interquartile range; BMI – body mass index; ILD – interstitial lung disease; COPD – chronic obstructive pulmonary disease; A1ATd – alpha-1 antitrypsin deficiency; CF – cystic fibrosis; PAH – pulmonary artery hypertension. | ||